Work

QL1706 (PD-1/CTLA-4 bispecific antibody) plus bevacizumab specific for patients with hepatocellular carcinoma combined with lung metastasis: A secondary analysis of a prospective, single-arm, phase Ib/II study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4114

Authors: Kunlin Xie, Hongzhao Yang, Weibing Leng, Chang Liu, Yu Yang, Xin Wang, Dan Cao, Hong Wu, Feng Bi

Institutions: Sichuan University, West China Hospital of Sichuan University, West China Medical Center of Sichuan University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162569812

Cites:

Cited by:

Related to: